Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Memorial Sloan Kettering Cancer Center
Yonsei University
Daiichi Sankyo
AstraZeneca